Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 19% ± 2% | |
epithelial cell | 4 studies | 30% ± 12% | |
myeloid cell | 3 studies | 17% ± 1% | |
fibroblast | 3 studies | 17% ± 0% | |
ciliated cell | 3 studies | 27% ± 3% | |
basal cell | 3 studies | 16% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5241.73 | 459 / 459 | 100% | 81.82 | 1118 / 1118 |
esophagus | 100% | 7154.06 | 1445 / 1445 | 100% | 50.10 | 183 / 183 |
prostate | 100% | 7736.09 | 245 / 245 | 100% | 64.68 | 502 / 502 |
skin | 100% | 7295.93 | 1809 / 1809 | 100% | 109.09 | 472 / 472 |
uterus | 100% | 8782.46 | 170 / 170 | 100% | 89.78 | 459 / 459 |
lung | 100% | 5857.83 | 578 / 578 | 100% | 65.38 | 1154 / 1155 |
thymus | 100% | 7117.18 | 653 / 653 | 100% | 75.49 | 604 / 605 |
intestine | 100% | 6910.14 | 966 / 966 | 100% | 53.54 | 526 / 527 |
bladder | 100% | 7049.95 | 21 / 21 | 100% | 62.05 | 503 / 504 |
ovary | 100% | 6715.73 | 180 / 180 | 100% | 54.16 | 429 / 430 |
pancreas | 100% | 3937.69 | 327 / 328 | 100% | 59.45 | 178 / 178 |
kidney | 100% | 5282.61 | 89 / 89 | 100% | 51.09 | 898 / 901 |
stomach | 100% | 5186.33 | 359 / 359 | 100% | 47.65 | 285 / 286 |
liver | 100% | 5733.89 | 226 / 226 | 100% | 43.11 | 404 / 406 |
brain | 99% | 3429.27 | 2618 / 2642 | 100% | 53.60 | 705 / 705 |
adrenal gland | 100% | 8248.15 | 258 / 258 | 98% | 50.91 | 225 / 230 |
adipose | 100% | 5549.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 74.65 | 29 / 29 |
spleen | 100% | 6837.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 105.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.64 | 1 / 1 |
blood vessel | 100% | 6505.77 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3036.65 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3227.26 | 854 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 65.16 | 79 / 80 |
peripheral blood | 76% | 3291.52 | 708 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006887 | Biological process | exocytosis |
GO_0042113 | Biological process | B cell activation |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0019905 | Molecular function | syntaxin binding |
Gene name | TXLNA |
Protein name | Alpha-taxilin TXLNA protein |
Synonyms | TXLN |
Description | FUNCTION: May be involved in intracellular vesicle traffic and potentially in calcium-dependent exocytosis in neuroendocrine cells. |
Accessions | A0AUK0 ENST00000373609.1 P40222 ENST00000373610.8 |